首页 > 期刊杂志 > 正文

Immunoglobulin Expressions Are Only Associated With MCPyV-positive Merkel Cell Carcinomas But Not With MCPyV-negative Ones: Comparison of Prognosis.

免疫球蛋白表达只与MCPyV阳性的默克尔细胞癌有关而与MCPyV阴性者无关:预后比较。

Murakami I,Takata K,Matsushita M,Nonaka D,Iwasaki T,Kuwamoto S,Kato M,Mohri T,Nagata K,Kitamura Y,Yoshino T,Hayashi K

Abstract

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer, often associated with Merkel cell polyomavirus (MCPyV). Recently, immunoglobulin (Ig) expression was reported in MCC, thereby suggesting that B cells might be their cellular ancestors. We tested 30 MCCs (20 MCPyV-positive and 10 MCPyV-negative) using immunohistochemistry for the expressions of IgG, IgA, IgM, Igκ, Igλ, terminal desoxynucleotidyl transferase, paired box gene 5 (PAX5), octamer transcription factor-2 (Oct-2), and sex-determining region Y-box 11 (SOX11). We performed in situ hybridization for Igκ-mRNA or Igλ-mRNA and Ig heavy chain (IgH) gene rearrangement (IgH-R) analyses. The expressions of PAX5, TdT, Oct-2, and SOX11 were not significantly different between MCPyV-positive and MCPyV-negative MCCs. At least 1 of IgG, IgA, IgM, or Igκ was expressed in MCPyV-positive (14/20, 70%) and none in MCPyV-negative MCCs (P=0.0003). There was a higher tendency for Igκ-mRNA expression (7/19, using in situ hybridization) and IgH-R (10/20, using polymerase chain reaction) in MCPyV-positive than in MCPyV-negative MCCs (0/10 and 2/10, respectively), thus suggesting a different Ig production pattern and pathogenesis between the 2 types of MCC. Ig expression or IgH-R in MCPyV-positive MCCs might be associated with MCPyV gene integration or expression in cancer cells but do not necessarily suggest a B-cell origin for MCCs. IgH expression or IgH-R nonsignificantly correlated with improved prognosis. However, these might be important factors that influence the survival of neoplastic cells and might allow the development of novel therapies for patients with MCPyV-positive MCCs.

摘要

默克尔细胞癌是一类侵袭性的神经内分泌皮肤癌,通常与默克尔细胞多瘤病毒(MCPyV)有关。最近,有报道称在MCC(默克尔细胞癌)中检测到免疫球蛋白(Ig)的表达,提示B细胞可能是其起源细胞,我们应用免疫组化检测了30例默克尔细胞癌(20例MCPyV阳性and10例MCPyV阴性)中IgG、IgA、IgM、Igκ、Igλ、末端脱氧核苷酸转移酶、配对盒基因5(PAX5)、八聚体转录因子2(Oct-2)、性别决定区Y-box11(SOX11)的表达。我们采用原位杂交进行Igκ-mRNA或Igλ-mRNA和Ig重链(IgH)基因重排(IgH-R)分析。PAX5、TdT、Oct-2和SOX11的表达在MCPyV阳性组和MCPyV阴性组无显着差异。IgG、IgA、IgM或Igκ中至少一种在MCPyV阳性的病例中表达(14/20,70%),而在MCPyV阴性的默克尔细胞癌中均不表达(P=0.0003)。在MCPyV阳性的默克尔细胞癌中Igκ-mRNA(7/19,应用原位杂交)和IgH-R(10/20,应用聚合酶链反应)的表达趋势较MCPyV阴性的默克尔细胞癌高(分别为0/10和2/10)。因而提示在两种不同类型的默克尔细胞癌中存在不同的Ig生成方式和致病机制。在MCPyV阳性的默克尔细胞癌中的Ig表达或IgH-R可能与癌细胞中MCPyV基因整合或表达有关,但不一定表明默克尔细胞癌起源于B细胞。IgH表达或IgH-R与默克尔细胞癌预后改善无显着相关。然而,这些可能是影响肿瘤细胞存活的重要因素,并且可能促进针对MCPyV阳性患者独特化疗的发展。

full text

我要评论

0条评论